Concepts (203)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Medicaid | 17 | 2025 | 353 | 3.800 |
Why?
|
| Nursing Homes | 12 | 2024 | 661 | 3.040 |
Why?
|
| Accountable Care Organizations | 9 | 2025 | 66 | 2.690 |
Why?
|
| Atrial Fibrillation | 7 | 2024 | 805 | 2.540 |
Why?
|
| Anticoagulants | 8 | 2024 | 480 | 2.270 |
Why?
|
| Medicare | 11 | 2025 | 601 | 1.830 |
Why?
|
| Stroke | 5 | 2023 | 1128 | 1.560 |
Why?
|
| United States | 33 | 2025 | 7429 | 1.500 |
Why?
|
| Homes for the Aged | 2 | 2021 | 157 | 1.210 |
Why?
|
| Hospitalization | 7 | 2025 | 1292 | 1.120 |
Why?
|
| Alzheimer Disease | 2 | 2024 | 681 | 1.110 |
Why?
|
| Memantine | 2 | 2024 | 22 | 1.070 |
Why?
|
| Hospices | 2 | 2025 | 34 | 1.060 |
Why?
|
| Hospice Care | 2 | 2025 | 62 | 1.020 |
Why?
|
| Cross-Sectional Studies | 14 | 2025 | 2382 | 0.970 |
Why?
|
| Patient-Centered Care | 3 | 2021 | 246 | 0.960 |
Why?
|
| Nutritional Support | 1 | 2025 | 12 | 0.950 |
Why?
|
| Aged | 22 | 2025 | 13423 | 0.950 |
Why?
|
| Food Assistance | 1 | 2025 | 17 | 0.950 |
Why?
|
| Skilled Nursing Facilities | 3 | 2023 | 83 | 0.880 |
Why?
|
| Potentially Inappropriate Medication List | 2 | 2021 | 14 | 0.870 |
Why?
|
| Dementia | 2 | 2024 | 248 | 0.860 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2023 | 37 | 0.850 |
Why?
|
| Humans | 50 | 2025 | 59424 | 0.840 |
Why?
|
| Inappropriate Prescribing | 2 | 2021 | 64 | 0.820 |
Why?
|
| Factor Xa Inhibitors | 2 | 2020 | 34 | 0.790 |
Why?
|
| Massachusetts | 10 | 2025 | 2021 | 0.770 |
Why?
|
| Emergency Service, Hospital | 4 | 2025 | 1022 | 0.770 |
Why?
|
| Warfarin | 2 | 2020 | 105 | 0.760 |
Why?
|
| Practice Patterns, Physicians' | 4 | 2020 | 692 | 0.730 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2022 | 112 | 0.720 |
Why?
|
| Medicare Part C | 1 | 2021 | 13 | 0.710 |
Why?
|
| Administration, Oral | 4 | 2024 | 355 | 0.710 |
Why?
|
| Aged, 80 and over | 13 | 2024 | 5126 | 0.680 |
Why?
|
| Antipsychotic Agents | 4 | 2024 | 293 | 0.620 |
Why?
|
| Rivaroxaban | 1 | 2018 | 19 | 0.620 |
Why?
|
| Activities of Daily Living | 1 | 2020 | 289 | 0.620 |
Why?
|
| Dabigatran | 1 | 2018 | 20 | 0.620 |
Why?
|
| Male | 25 | 2025 | 27772 | 0.610 |
Why?
|
| Italy | 6 | 2021 | 63 | 0.600 |
Why?
|
| Brain Ischemia | 2 | 2019 | 399 | 0.600 |
Why?
|
| Female | 25 | 2025 | 30753 | 0.590 |
Why?
|
| Metformin | 1 | 2019 | 64 | 0.590 |
Why?
|
| Subacute Care | 1 | 2017 | 9 | 0.570 |
Why?
|
| Rehabilitation Centers | 1 | 2017 | 12 | 0.570 |
Why?
|
| Head and Neck Neoplasms | 1 | 2019 | 148 | 0.570 |
Why?
|
| Hypoglycemic Agents | 1 | 2019 | 192 | 0.550 |
Why?
|
| Stroke Rehabilitation | 1 | 2017 | 46 | 0.540 |
Why?
|
| Ambulatory Care | 1 | 2019 | 304 | 0.540 |
Why?
|
| Cohort Studies | 5 | 2024 | 2376 | 0.500 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2021 | 454 | 0.500 |
Why?
|
| General Practitioners | 1 | 2015 | 14 | 0.490 |
Why?
|
| Hemorrhage | 3 | 2024 | 260 | 0.480 |
Why?
|
| Drug Utilization | 3 | 2021 | 208 | 0.460 |
Why?
|
| Nurses | 1 | 2015 | 102 | 0.450 |
Why?
|
| Retrospective Studies | 7 | 2024 | 6077 | 0.440 |
Why?
|
| Health Care Costs | 3 | 2025 | 202 | 0.430 |
Why?
|
| Cholinesterase Inhibitors | 2 | 2024 | 45 | 0.430 |
Why?
|
| Cost of Illness | 1 | 2014 | 156 | 0.420 |
Why?
|
| Biopsy | 1 | 2014 | 410 | 0.410 |
Why?
|
| Proportional Hazards Models | 6 | 2022 | 674 | 0.410 |
Why?
|
| Patient Care Team | 1 | 2015 | 329 | 0.400 |
Why?
|
| Managed Care Programs | 2 | 2025 | 88 | 0.400 |
Why?
|
| Health Equity | 2 | 2023 | 42 | 0.390 |
Why?
|
| Mammography | 1 | 2014 | 271 | 0.380 |
Why?
|
| Early Detection of Cancer | 1 | 2014 | 266 | 0.370 |
Why?
|
| Treatment Outcome | 6 | 2024 | 5285 | 0.370 |
Why?
|
| Middle Aged | 13 | 2025 | 16330 | 0.360 |
Why?
|
| Attitude of Health Personnel | 1 | 2015 | 551 | 0.360 |
Why?
|
| Fee-for-Service Plans | 2 | 2021 | 66 | 0.350 |
Why?
|
| Primary Health Care | 3 | 2025 | 649 | 0.350 |
Why?
|
| Quality of Life | 1 | 2017 | 1138 | 0.350 |
Why?
|
| Bipolar Disorder | 2 | 2022 | 243 | 0.330 |
Why?
|
| Medication Adherence | 3 | 2022 | 241 | 0.330 |
Why?
|
| Mass Screening | 1 | 2014 | 648 | 0.310 |
Why?
|
| Adult | 10 | 2025 | 15693 | 0.290 |
Why?
|
| Cognition Disorders | 2 | 2021 | 215 | 0.290 |
Why?
|
| Sex Factors | 3 | 2021 | 935 | 0.280 |
Why?
|
| Socioeconomic Factors | 3 | 2022 | 742 | 0.270 |
Why?
|
| Child | 4 | 2025 | 4193 | 0.260 |
Why?
|
| Qualitative Research | 3 | 2025 | 619 | 0.260 |
Why?
|
| Age Factors | 3 | 2021 | 1505 | 0.260 |
Why?
|
| Breast Neoplasms | 1 | 2014 | 1118 | 0.250 |
Why?
|
| Time Factors | 3 | 2019 | 3620 | 0.240 |
Why?
|
| Social Determinants of Health | 3 | 2022 | 122 | 0.240 |
Why?
|
| Health Care Reform | 2 | 2023 | 85 | 0.240 |
Why?
|
| Meals | 1 | 2025 | 23 | 0.240 |
Why?
|
| Residence Characteristics | 3 | 2023 | 215 | 0.240 |
Why?
|
| Food Services | 1 | 2025 | 27 | 0.230 |
Why?
|
| Nurse Administrators | 1 | 2024 | 18 | 0.230 |
Why?
|
| Comparative Effectiveness Research | 1 | 2024 | 45 | 0.230 |
Why?
|
| Surveys and Questionnaires | 3 | 2024 | 2517 | 0.220 |
Why?
|
| Prescriptions | 1 | 2023 | 30 | 0.210 |
Why?
|
| Deprescriptions | 1 | 2023 | 24 | 0.210 |
Why?
|
| Comorbidity | 3 | 2021 | 1078 | 0.210 |
Why?
|
| Social Responsibility | 1 | 2022 | 11 | 0.200 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2023 | 94 | 0.200 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2021 | 657 | 0.200 |
Why?
|
| Longitudinal Studies | 3 | 2021 | 1188 | 0.200 |
Why?
|
| Pediatrics | 1 | 2024 | 241 | 0.190 |
Why?
|
| Racism | 1 | 2023 | 81 | 0.190 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2024 | 725 | 0.190 |
Why?
|
| Risk Factors | 2 | 2023 | 4990 | 0.190 |
Why?
|
| Life Expectancy | 1 | 2021 | 34 | 0.190 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2022 | 64 | 0.190 |
Why?
|
| Health Personnel | 1 | 2025 | 342 | 0.180 |
Why?
|
| Drug Repositioning | 1 | 2021 | 6 | 0.180 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2022 | 142 | 0.180 |
Why?
|
| Young Adult | 5 | 2025 | 4273 | 0.170 |
Why?
|
| Quality Indicators, Health Care | 2 | 2021 | 333 | 0.170 |
Why?
|
| Cognition | 1 | 2023 | 454 | 0.160 |
Why?
|
| Anticonvulsants | 1 | 2020 | 88 | 0.160 |
Why?
|
| Drug Substitution | 1 | 2019 | 40 | 0.160 |
Why?
|
| Geographic Mapping | 1 | 2018 | 6 | 0.150 |
Why?
|
| Epilepsy | 1 | 2020 | 105 | 0.150 |
Why?
|
| Pancreatic Neoplasms | 1 | 2022 | 331 | 0.150 |
Why?
|
| Drug Prescriptions | 1 | 2020 | 168 | 0.150 |
Why?
|
| Thromboembolism | 1 | 2018 | 69 | 0.150 |
Why?
|
| Health Services Accessibility | 1 | 2023 | 527 | 0.150 |
Why?
|
| Intracranial Hemorrhages | 1 | 2018 | 61 | 0.150 |
Why?
|
| Adolescent | 4 | 2025 | 5842 | 0.150 |
Why?
|
| Motivation | 1 | 2020 | 274 | 0.150 |
Why?
|
| Health Care Surveys | 1 | 2019 | 279 | 0.150 |
Why?
|
| Secondary Prevention | 1 | 2018 | 151 | 0.150 |
Why?
|
| Pneumococcal Vaccines | 1 | 2017 | 19 | 0.150 |
Why?
|
| Health Services Research | 1 | 2019 | 266 | 0.140 |
Why?
|
| Ischemic Attack, Transient | 1 | 2018 | 90 | 0.140 |
Why?
|
| Pneumococcal Infections | 1 | 2017 | 35 | 0.140 |
Why?
|
| Physicians | 1 | 2023 | 440 | 0.140 |
Why?
|
| Body Mass Index | 1 | 2021 | 831 | 0.140 |
Why?
|
| Delayed-Action Preparations | 1 | 2017 | 111 | 0.140 |
Why?
|
| Calcium Channel Blockers | 1 | 2017 | 57 | 0.140 |
Why?
|
| Disability Evaluation | 1 | 2017 | 199 | 0.130 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2017 | 147 | 0.130 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2015 | 58 | 0.120 |
Why?
|
| Salvage Therapy | 1 | 2015 | 71 | 0.120 |
Why?
|
| Physician-Nurse Relations | 1 | 2015 | 26 | 0.120 |
Why?
|
| Schizophrenia | 1 | 2017 | 247 | 0.120 |
Why?
|
| Medicine | 1 | 2015 | 57 | 0.120 |
Why?
|
| Pneumonia | 1 | 2017 | 282 | 0.120 |
Why?
|
| False Positive Reactions | 1 | 2014 | 76 | 0.110 |
Why?
|
| Interprofessional Relations | 1 | 2015 | 129 | 0.110 |
Why?
|
| Mental Disorders | 1 | 2021 | 720 | 0.110 |
Why?
|
| Acute Coronary Syndrome | 1 | 2017 | 250 | 0.110 |
Why?
|
| Length of Stay | 1 | 2017 | 779 | 0.110 |
Why?
|
| Insurance Coverage | 1 | 2014 | 99 | 0.110 |
Why?
|
| Analgesics, Opioid | 1 | 2018 | 483 | 0.110 |
Why?
|
| Health Promotion | 1 | 2017 | 471 | 0.110 |
Why?
|
| Patient Readmission | 1 | 2017 | 421 | 0.110 |
Why?
|
| Medicare Part D | 2 | 2025 | 37 | 0.100 |
Why?
|
| Interviews as Topic | 2 | 2025 | 484 | 0.100 |
Why?
|
| Prostatic Neoplasms | 1 | 2015 | 339 | 0.100 |
Why?
|
| Myocardial Infarction | 1 | 2018 | 863 | 0.100 |
Why?
|
| Insurance Claim Review | 2 | 2022 | 76 | 0.080 |
Why?
|
| Pharmacists | 2 | 2023 | 123 | 0.080 |
Why?
|
| Quality of Health Care | 2 | 2023 | 514 | 0.080 |
Why?
|
| Needs Assessment | 1 | 2024 | 187 | 0.050 |
Why?
|
| Health Policy | 1 | 2025 | 177 | 0.050 |
Why?
|
| Health Services Needs and Demand | 1 | 2024 | 203 | 0.050 |
Why?
|
| Housing | 1 | 2023 | 72 | 0.050 |
Why?
|
| Personal Satisfaction | 1 | 2023 | 76 | 0.050 |
Why?
|
| Risk Adjustment | 1 | 2023 | 93 | 0.050 |
Why?
|
| Income | 1 | 2023 | 157 | 0.050 |
Why?
|
| Pilot Projects | 1 | 2025 | 915 | 0.050 |
Why?
|
| Poverty | 1 | 2023 | 283 | 0.050 |
Why?
|
| Interinstitutional Relations | 1 | 2021 | 37 | 0.040 |
Why?
|
| Administrative Personnel | 1 | 2021 | 29 | 0.040 |
Why?
|
| Multimorbidity | 1 | 2021 | 43 | 0.040 |
Why?
|
| Palliative Care | 1 | 2023 | 214 | 0.040 |
Why?
|
| Survival Rate | 1 | 2022 | 801 | 0.040 |
Why?
|
| Cooperative Behavior | 1 | 2021 | 210 | 0.040 |
Why?
|
| Proteomics | 1 | 2021 | 263 | 0.040 |
Why?
|
| Quality Improvement | 1 | 2023 | 418 | 0.040 |
Why?
|
| Communication | 1 | 2023 | 546 | 0.040 |
Why?
|
| Genomics | 1 | 2021 | 319 | 0.040 |
Why?
|
| Senior Centers | 1 | 2017 | 1 | 0.040 |
Why?
|
| Electronic Health Records | 1 | 2021 | 342 | 0.040 |
Why?
|
| Research Design | 1 | 2021 | 556 | 0.040 |
Why?
|
| Injections | 1 | 2017 | 76 | 0.040 |
Why?
|
| Costs and Cost Analysis | 1 | 2017 | 98 | 0.030 |
Why?
|
| Taiwan | 1 | 2017 | 8 | 0.030 |
Why?
|
| Registries | 1 | 2021 | 801 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2017 | 284 | 0.030 |
Why?
|
| Health Resources | 1 | 2017 | 88 | 0.030 |
Why?
|
| Linear Models | 1 | 2017 | 403 | 0.030 |
Why?
|
| Bias | 1 | 2017 | 108 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 396 | 0.030 |
Why?
|
| Propensity Score | 1 | 2017 | 144 | 0.030 |
Why?
|
| Pandemics | 1 | 2021 | 617 | 0.030 |
Why?
|
| Mortality | 1 | 2017 | 155 | 0.030 |
Why?
|
| Prevalence | 1 | 2020 | 1254 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2017 | 805 | 0.030 |
Why?
|
| Incidence | 1 | 2019 | 1239 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 903 | 0.030 |
Why?
|
| Prostatectomy | 1 | 2015 | 64 | 0.030 |
Why?
|
| Patient Compliance | 1 | 2017 | 349 | 0.030 |
Why?
|
| Vaccination | 1 | 2017 | 335 | 0.030 |
Why?
|
| Inpatients | 1 | 2017 | 292 | 0.030 |
Why?
|
| Substance-Related Disorders | 1 | 2021 | 687 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2017 | 814 | 0.030 |
Why?
|
| Disease Progression | 1 | 2017 | 1119 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 2338 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2017 | 1926 | 0.020 |
Why?
|